CERN is specialized for particle physics and conduct the largest particle physics lab in the world. CERN along with Lausanne University Hospital (CHUV) will develop the theoritical design of a new radiotherapy for cancer cure.
The technology will be able to boost a cancer-fighting medical technique known as FLASH radiotherapy delivering high energy electrons for the treatment of tumors as mentioned in the post of CERN’s official website. The result will give an amazing form of cancer treatment and it will be able to reach deep into the body of the patient giving a very less side effect. The completion of the first phase of the study will come to an end this September.
In this process, the FLASH effect distributes a high dose of radiation instantly ( in milliseconds rather than a minute). The tumor tissue is destroyed in the same way as in regular radiotherapy, but the healthy tissue is affected minorly which means side effect is least expected.
The amazing FLASH Therapy was identified at CHUV which established the development of the field.
“In 2018, CHUV showed complete disappearance of a tumor in resistant superficial skin cancer, with nearly no side effects. This first for FLASH treatment on humans accelerated the clinical translation of FLASH therapy,” mentioned Prof. Bourhis, Head of Radiation Oncology at CHUV, in a report.
Doses for the cure takes less than a second –
FLASH radiotherapy can provide the necessary dose of radiation in a few hearings. Each of them would take less than a second rather than having many sessions of a few minutes each.
The most important problem was to achieve high-energy electrons using compact linear accelerators. CERN and CHUV then came up with a quick fix for the issue from the conceptual design of an exclusive apparatus based on the CLIC (Compact Linear Collider) accelerator technology, which will accelerate electrons to cure tumours up to 15 to 20 cm in extent.
“Using the CLIC high-performance linear electron accelerator technology, we designed a facility that is capable of treating large and deep-seated tumours in the very short timescales needed for FLASH therapy,” explains Walter Wuensch, project leader at CERN.
“Particle physics sits at the interface between fundamental science and key technological breakthroughs. The collaboration between CERN and CHUV demonstrates again how CERN technologies, unique facilities, and expertise can benefit society beyond their use for our fundamental research,” says Frédérick Bordry, CERN’s Director for Accelerators and Technology and Chair of the CERN Medical Applications Steering Committee.
“CHUV is centred on clinical excellence and patient-centric care. These values, together with the unique opportunities for development and innovation that the region offers, allow us to achieve great breakthroughs. We are particularly proud of our collaboration with CERN and strongly believe in the advancement of FLASH radiotherapy into a clinical setting,” commented Prof. Philippe Eckert, CHUV Director-General.
The new process has become convenient enough to put it for the service in the hospitals and it is expected to make a massive change for the patient suffering from cancer.
Source – cern